Novartis AGNVSNYSE
Loading
Total earnings after all expenses, taxes, and interest
3Y CAGR
+26.4%/yr
vs -13.8%/yr prior
5Y CAGR
+11.7%/yr
Recent acceleration
Acceleration
+40.3pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $14.06B | +17.7% |
| 2024 | $11.94B | -19.6% |
| 2023 | $14.85B | +113.5% |
| 2022 | $6.96B | -71.0% |
| 2021 | $24.02B | +197.6% |
| 2020 | $8.07B | -31.2% |
| 2019 | $11.73B | -7.0% |
| 2018 | $12.61B | +63.7% |
| 2017 | $7.70B | +14.8% |
| 2016 | $6.71B | - |